Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Four weeks after starting Mounjaro, Clare Meadowcroft was hospitalised for 10 days with acute pancreatitis and underwent ...

A MUM thought her weight loss jabs were giving her trapped wind until she was racked by pains “worse than labour”, forcing ...

BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...

The 42-year-old athlete told the news outlet that her weight loss journey became particularly challenging following the ...

Fans rubbed their eyes in disbelief after Meghan Trainor shared a video of herself attempting a wild and risky challenge ...

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

C-store retailers answer this Rovertown ‘hot, or not’ question as well others on GLP-1, Gen Zers and more at Outlook Leadership ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication ...

Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes ...